Pao-Yu Chen

Pao-Yu Chen

Auto-generated profile, based on publicly available information

Pao-Yu Chen

Division of Infectious Diseases, Department of Internal Medicine, National Taiwan University Hospital , Taipei

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 November 2023 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
PCPao-Yu Chen
Pao-Yu Chen
YHYu-Shan Huang
Yu-Shan Huang
YCYu-Chung Chuang
Yu-Chung Chuang
Jann-Yuan WangJann-Yuan Wang
Jann-Yuan Wang
WSWang-Huei Sheng
Wang-Huei Sheng
SCShan-Chwen Chang
Shan-Chwen Chang
Genotyping a specific pathogen may demonstrate unique patterns of antimicrobial resistance and/or interaction between pathogen and host, which subsequently lead to miserable consequence. Herein, we conducted a retrospective single-center study to analyze the association between genotypes and clinical outcomes among Candida glabrata bloodstream infections (BSIs). A standard case report form was used to collect the clinical data of hospitalized adults with C. glabrata BSIs in 2017. Antifungal susceptibility testing was performed by using the Sensititre YeastOne SYO-10 panel, and minimum inhibitory concentrations (MICs) were interpretated according to the Clinical and Laboratory Standard Institute. Genotyping was performed by using a multilocus sequence typing scheme, and further analyzed by the unweighted pair group method with arithmetic averages (UPGMA) method. Comparison of Kaplan–Meier survival curves between cloncal complex 7 (CC7) and non-cloncal complex 7 (non-CC7) at 28 days in patients with Candida glabrata bloodstream infections Our data shed light on the impact of genotypes on clinical outcomes in C. glabrata BSIs. Further virulence characterization of CC7 is warranted. All Authors: No reported disclosures

16 September 2026 in eClinicalMedicine
Verified
Journal Article
Open access
IRIlana Reinhold
Ilana Reinhold
IRIsabel Cristina Ramirez-Sanchez
Isabel Cristina Ramirez-Sanchez
PCPao-Yu Chen
Pao-Yu Chen
Yang-ching ChenYang-ching Chen
Yang-ching Chen
ADAnkush Dhariwal
Ankush Dhariwal
LZLaura Zager
Laura Zager

1 September 2026 in JAC-Antimicrobial Resistance
Verified
Journal Article
Open access
WLWei-Ting Lin
Wei-Ting Lin
PCPao-Yu Chen
Pao-Yu Chen
TWTzong-Yow Wu
Tzong-Yow Wu
JLJheng-Wei Lin
Jheng-Wei Lin
SHSong-Chou Hsieh
Song-Chou Hsieh
Yang-ching ChenYang-ching Chen
Yang-ching Chen

1 September 2026 in JAC-Antimicrobial Resistance
Verified
Journal Article
Open access
PCPao-Yu Chen
Pao-Yu Chen
UWUn-In Wu
Un-In Wu
WLWang-Da Liu
Wang-Da Liu
YHYu-Tsung Huang
Yu-Tsung Huang
YCYee-Chun Chen
Yee-Chun Chen
Objectives: Despite the global emergence of Fusarium infections, data validating commercial antifungal susceptibility testing against these moulds remain scarce. We evaluated the performance and optimal reading time of the Sensititre YeastOne (SYO) assay against Fusarium clinical isolates compared with the EUCAST reference method. Methods: This two-centre study (2011–2023) analysed 123 Fusarium isolates identified via two-step molecular sequencing. In vitro susceptibilities to voriconazole and amphotericin B were evaluated using SYO (24 h and 48 h readouts) versus the EUCAST E.Def 9.4 broth microdilution reference method (48 h readout). Essential agreement (EA) was defined as a ±2 log2 dilution difference; >90% was acceptable. Results: Fusarium solani species complex (FSSC) dominated the cohort (85.3%), predominantly F. keratoplasticum and F. pseudensiforme. EUCAST testing revealed high MIC50/MIC90 values of voriconazole (>16/>16 mg/L) and amphotericin B (2/16 mg/L). While 65% (80/123) of isolates displayed positivity by SYO at 24 h, median spectrophotometric growth was significantly greater at 48 h than at 24 h [0.37 (IQR 0.315–0.403) versus 0.18 (0.151–0.206)]. At 48 h, EA approached acceptability for voriconazole (92.7%) and amphotericin B (89.4%). Voriconazole categorical agreement (CA) among FSSC was 88.6% and reached 96.9% for F. pseudensiforme. For amphotericin B, SYO MICs clustered around 4–8 mg/L, yielding 100% very major error for F. keratoplasticum and F. pseudensiforme but 100% CA for F. falciforme, F. petroliphilum and non-FSSC. Conclusions: Voriconazole and amphotericin B susceptibility determined by SYO cannot universally replace reference methods due to failure to detect non-WT to amphotericin B for prevalent species within FSSC. However, alongside accurate species-level molecular identification, SYO provides actionable susceptibility data for validated species-antifungal combinations.

26 August 2026 in Annals of Medicine
Verified
Journal Article
Open access
MTMing-Tao Tsai
Ming-Tao Tsai
PCPao-Yu Chen
Pao-Yu Chen
THTai-Chung Huang
Tai-Chung Huang
JWJann-Tay Wang
Jann-Tay Wang
WCWen-Chien Chou
Wen-Chien Chou
YCYee-Chun Chen
Yee-Chun Chen
Invasive fungal infections (IFIs) remain a major cause of morbidity and mortality among patients with haematological malignancies [1], particularly those with acute leukaemia [2] and haematopoietic...

6 February 2026 in CMI Communications
Verified
Journal Article
Open access
CWChia-Jung Wu
Chia-Jung Wu
TWTzong-Yow Wu
Tzong-Yow Wu
PCPao-Yu Chen
Pao-Yu Chen
HHHsin-An Hou
Hsin-An Hou
YCYee-Chun Chen
Yee-Chun Chen